Who invested in BlackThorn Therapeutics

2 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$90Mraised across 2 rounds since 2017, from 2 sources

$14MSeries A$76MSeries B

Latest round: Series B, $76MJun 2019
Step-upi: 5.4×
Investors: 12

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201720182019

$14MSeries A$76MSeries B

First round: Series A, $14M
Biggest round: $76M
Between rounds: 2.4 years

The rounds

Jun 2019
Series B$76M10 new2 returning
Reported by FinSMEs
Jan 2017
Series A$14M2 new
- Google Ventures
- Biomatics Capital
Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2017Series B2019

Google Ventures

Biomatics Capital

Polaris Partners

ARCH Venture Partners

Mercury Fund

Google

Alexandria Real Estate Equities

Premier PartnersJohnson & Johnson Innovation

Altitude Life Science Ventures

Everyone who backed them

Google VenturesCorporate VC2rounds

Biomatics CapitalVC firm2rounds

Polaris PartnersVC firm1round

ARCH Venture PartnersVC firm1round

Mercury FundVC firm1round

GoogleAccelerator1round

Alexandria Real Estate EquitiesVC firm1round

Premier PartnersVC firm1round

Johnson & Johnson InnovationGrowth equity1round

Altitude Life Science VenturesVC firm1round

Vertex Ventures HCVC firm1round

Scripps ResearchVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about BlackThorn Therapeutics

Who invested in BlackThorn Therapeutics?

BlackThorn Therapeutics's investors include Google Ventures, Biomatics Capital, Polaris Partners, ARCH Venture Partners and Mercury Fund, and 7 more on record.